Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
Filter | GSE237611 | CSV | |||||||
GSM7634797 |
donor T1DAL_365106, alefacept treated, 104 wk post-treatment, responder (R), single cell TCR-seq
|
SRA | 1 |
|
|
Stephanie Osmond | Jan 17, 2024 | ||
GSM7634798 |
donor T1DAL_799347, alefacept treated, 104 wk post-treatment, responder (R), single cell TCR-seq
|
SRA | 1 |
|
|
Stephanie Osmond | Jan 17, 2024 | ||
GSM7634799 |
donor T1DAL_325261, alefacept treated, 104 wk post-treatment, non-responder (NR), single cell TCR-seq
|
SRA | 1 |
|
|
Stephanie Osmond | Jan 17, 2024 | ||
GSM7634800 |
donor T1DAL_671942, alefacept treated, 104 wk post-treatment, non-responder (NR), single cell TCR-seq
|
SRA | 1 |
|
|
Stephanie Osmond | Jan 17, 2024 | ||
GSM7634801 |
donor T1DAL_616755, alefacept treated, 104 wk post-treatment, responder (R), single cell TCR-seq
|
SRA | 1 |
|
|
Stephanie Osmond | Jan 17, 2024 | ||
GSM7634802 |
donor T1DAL_923889, alefacept treated, 104 wk post-treatment, non-responder (NR), single cell TCR-seq
|
SRA | 1 |
|
|
Stephanie Osmond | Jan 17, 2024 | ||
GSM7634803 |
donor T1DAL_442289, alefacept treated, 104 wk post-treatment, non-responder (NR), single cell TCR-seq
|
SRA | 1 |
|
|
Stephanie Osmond | Jan 17, 2024 | ||
GSM7634804 |
donor T1DAL_323347, alefacept treated, 104 wk post-treatment, responder (R), single cell TCR-seq
|
SRA | 1 |
|
|
Stephanie Osmond | Jan 17, 2024 | ||
GSM7634805 |
donor T1DAL_947702, alefacept treated, 104 wk post-treatment, non-responder (NR), single cell TCR-seq
|
SRA | 1 |
|
|
Stephanie Osmond | Jan 17, 2024 | ||
GSM7634806 |
donor T1DAL_769151, alefacept treated, 104 wk post-treatment, responder (R), single cell TCR-seq
|
SRA | 1 |
|
|
Stephanie Osmond | Jan 17, 2024 | ||
GSM7634807 |
donor T1DAL_243767, alefacept treated, 104 wk post-treatment, responder (R), single cell TCR-seq
|
SRA | 1 |
|
|
Stephanie Osmond | Jan 17, 2024 | ||
GSM7634808 |
donor T1DAL_576351, alefacept treated, 104 wk post-treatment, non-responder (NR), single cell TCR-seq
|
SRA | 1 |
|
|
Stephanie Osmond | Jan 17, 2024 |